On the public citation graph
A guide to enzyme kinetics in early drug discovery
0 signed · 103 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/9781118540398openalex-snapshot
Evaluation of Enzyme Inhibitors in Drug Discovery
inferredcites →https://doi.org/10.1002/cmdc.201500310openalex-snapshot
The Role of Target Binding Kinetics in Drug Discovery
inferredcites →https://doi.org/10.1002/cmdc.202000791openalex-snapshot
Explicit Treatment of Non‐Michaelis‐Menten and Atypical Kinetics in Early Drug Discovery**
inferredcites →https://doi.org/10.1002/med.21670openalex-snapshot
Resurrecting the phoenix: When an assay fails
inferredcites →https://doi.org/10.1007/s00018-019-03376-yopenalex-snapshot
Multi-scale modeling of drug binding kinetics to predict drug efficacy
inferredcites →https://doi.org/10.1016/b978-0-12-381274-2.00012-1openalex-snapshot
HTS Reporter Displacement Assay for Fragment Screening and Fragment Evolution Toward Leads with Optimized Binding Kinetics, Binding Selectivity, and Thermodynamic Signature
inferredcites →https://doi.org/10.1016/j.bcp.2016.02.018openalex-snapshot
Equilibrium and kinetic selectivity profiling on the human adenosine receptors
inferredcites →https://doi.org/10.1016/j.bmcl.2015.02.027openalex-snapshot
Design strategies to address kinetics of drug binding and residence time
inferredcites →https://doi.org/10.1016/j.cbpa.2018.06.002openalex-snapshot
Structure–kinetic relationships that control the residence time of drug–target complexes: insights from molecular structure and dynamics
inferredcites →https://doi.org/10.1016/j.cbpa.2019.03.008openalex-snapshot
Pharmacokinetic–pharmacodynamic models that incorporate drug–target binding kinetics
inferredcites →https://doi.org/10.1016/j.chembiol.2021.01.003openalex-snapshot
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2
inferredcites →https://doi.org/10.1016/j.ddtec.2015.08.003openalex-snapshot
On-rate based optimization of structure–kinetic relationship – surfing the kinetic map
inferredcites →https://doi.org/10.1016/j.drudis.2013.02.007openalex-snapshot
Molecular determinants of drug–receptor binding kinetics
inferredcites →https://doi.org/10.1016/j.drudis.2013.02.010openalex-snapshot
Pharmacokinetics and the drug–target residence time concept
inferredcites →https://doi.org/10.1016/j.drudis.2017.02.002openalex-snapshot
Kinetics for Drug Discovery: an industry-driven effort to target drug residence time
inferredcites →https://doi.org/10.1016/j.drudis.2019.09.011openalex-snapshot
The importance of target binding kinetics for measuring target binding affinity in drug discovery: a case study from a CRF1 receptor antagonist program
inferredcites →https://doi.org/10.1016/j.febslet.2013.06.009openalex-snapshot
The origins of enzyme kinetics
inferredcites →https://doi.org/10.1016/j.jtbi.2018.02.014openalex-snapshot
Kinetic operational models of agonism for G-protein-coupled receptors
inferredcites →https://doi.org/10.1016/j.tibs.2019.04.004openalex-snapshot
Drug–Target Association Kinetics in Drug Discovery
inferredcites →https://doi.org/10.1016/j.tips.2016.06.008openalex-snapshot
In vivo Target Residence Time and Kinetic Selectivity: The Association Rate Constant as Determinant
inferredcites →https://doi.org/10.1016/s0021-9258(18)60389-8openalex-snapshot
The Enzymology of Control by Feedback Inhibition
inferredcites →https://doi.org/10.1016/s0026-895x(25)15016-5openalex-snapshot
The kinetics of competitive radioligand binding predicted by the law of mass action.
inferredcites →https://doi.org/10.1016/s0076-6879(09)67023-3openalex-snapshot
Chapter 23 Fitting Enzyme Kinetic Data with KinTek Global Kinetic Explorer
inferredcites →https://doi.org/10.1016/s0303-2647(98)00020-3openalex-snapshot
Development of fractal kinetic theory for enzyme-catalysed reactions and implications for the design of biochemical pathways
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b00518openalex-snapshot
Structure–Affinity Relationships (SARs) and Structure–Kinetics Relationships (SKRs) of Kv11.1 Blockers
inferredcites →https://doi.org/10.1021/acschembio.6b00074openalex-snapshot
Conformational Adaption May Explain the Slow Dissociation Kinetics of Roniciclib (BAY 1000394), a Type I CDK Inhibitor with Kinetic Selectivity for CDK2 and CDK9
inferredcites →https://doi.org/10.1021/acschemneuro.7b00185openalex-snapshot
Drug–Target Kinetics in Drug Discovery
inferredcites →https://doi.org/10.1021/ar000058iopenalex-snapshot
The Depth of Chemical Time and the Power of Enzymes as Catalysts
inferredcites →https://doi.org/10.1021/jacs.9b02822openalex-snapshot
Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
inferredcites →https://doi.org/10.1021/jm4011737openalex-snapshot
Structure–Kinetic Relationships—An Overlooked Parameter in Hit-to-Lead Optimization: A Case of Cyclopentylamines as Chemokine Receptor 2 Antagonists
inferredcites →https://doi.org/10.1021/ml500394mopenalex-snapshot
Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization
inferredcites →https://doi.org/10.1021/ml900002kopenalex-snapshot
Fragment Screening by Surface Plasmon Resonance
inferredcites →https://doi.org/10.1038/nchembio.1629openalex-snapshot
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
inferredcites →https://doi.org/10.1038/nchembio.1796openalex-snapshot
Translating slow-binding inhibition kinetics into cellular and in vivo effects
inferredcites →https://doi.org/10.1038/nrd.2015.18openalex-snapshot
The drug–target residence time model: a 10-year retrospective
inferredcites →https://doi.org/10.1038/nrd.2018.234openalex-snapshot
The implications of target saturation for the use of drug–target residence time
inferredcites →https://doi.org/10.1038/nrd2082openalex-snapshot
Drug–target residence time and its implications for lead optimization
inferredcites →https://doi.org/10.1038/s41594-018-0061-5openalex-snapshot
The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors
inferredcites →https://doi.org/10.1039/c3mb25471bopenalex-snapshot
A comprehensive analysis of the influence of drug binding kinetics on drug action at molecular and systems levels
inferredcites →https://doi.org/10.1039/c6sc01000hopenalex-snapshot
Correlating drug–target kinetics and in vivo pharmacodynamics: long residence time inhibitors of the FabI enoyl-ACP reductase
inferredcites →https://doi.org/10.1039/c6sc03306gopenalex-snapshot
A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacy
inferredcites →https://doi.org/10.1042/bj20090121openalex-snapshot
Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1
inferredcites →https://doi.org/10.1073/pnas.1313733111openalex-snapshot
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance
inferredcites →https://doi.org/10.1073/pnas.2111451118openalex-snapshot
Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance
inferredcites →https://doi.org/10.1111/febs.12727openalex-snapshot
Allosteric regulation and substrate activation in cytosolic nucleotidase II from L egionella pneumophila
inferredcites →https://doi.org/10.1111/febs.15537openalex-snapshot
Words of Advice: teaching enzyme kinetics
inferredcites →https://doi.org/10.1111/febs.16124openalex-snapshot
A guide to the Michaelis–Menten equation: steady state and beyond
inferredcites →https://doi.org/10.1124/jpet.119.262063openalex-snapshot
Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib
inferredcites →https://doi.org/10.1158/0008-5472.can-04-1443openalex-snapshot
BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis
inferredcites →https://doi.org/10.1177/2472555217695080openalex-snapshot
A High-Throughput Method for Measuring Drug Residence Time Using the Transcreener ADP Assay
inferredcites →https://doi.org/10.1177/24725552211000676openalex-snapshot
A Novel High-Throughput FLIPR Tetra–Based Method for Capturing Highly Confluent Kinetic Data for Structure–Kinetic Relationship Guided Early Drug Discovery
inferredcites →https://doi.org/10.1177/24725552211019653openalex-snapshot
The Problems of Applying Classical Pharmacology Analysis to Modern In Vitro Drug Discovery Assays: Slow Binding Kinetics and High Target Concentration
inferredcites →https://doi.org/10.1182/blood-2013-04-497644openalex-snapshot
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
inferredcites →https://doi.org/10.1517/17460441003677725openalex-snapshot
The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
inferredcites →https://doi.org/10.1529/biophysj.104.042143openalex-snapshot
Michaelis-Menten Kinetics under Spatially Constrained Conditions: Application to Mibefradil Pharmacokinetics
inferredcites →https://doi.org/10.2741/4470openalex-snapshot
Binding kinetics in drug discovery ndash A current perspective
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cmdc.202400417openalex-snapshot
The Role of Water Networks in Phosphodiesterase Inhibitor Dissociation and Kinetic Selectivity
inferred← citeshttps://doi.org/10.1002/cmdc.202400520openalex-snapshot
Profiling Cysteine Proteases Activities in Neuroinflammatory Cells
inferred← citeshttps://doi.org/10.1007/s00259-025-07160-yopenalex-snapshot
FAP inhibitors: are we really using the best method to evaluate the residence time?
inferred← citeshttps://doi.org/10.1007/s10532-025-10145-1openalex-snapshot
Bioremediation of Cr(VI) using novel thermophilic bacteria Brevibacillus borstelensis SSAU-3 T: optimization, mechanism and phytotoxicity study
inferred← citeshttps://doi.org/10.1016/bs.mie.2023.06.015openalex-snapshot
Steady-state kinetic analysis of reversible enzyme inhibitors: A case study on calf intestine alkaline phosphatase
inferred← citeshttps://doi.org/10.1016/bs.mie.2023.08.004openalex-snapshot
Non-equilibrium modalities of inhibition: Characterizing irreversible inhibition for the ErbB receptor family members
inferred← citeshttps://doi.org/10.1016/j.bbrc.2026.153300openalex-snapshot
smFASTIA: A high-sensitivity platform for purification-free kinetic screening of protein–small molecule interactions
inferred← citeshttps://doi.org/10.1016/j.bios.2025.117192openalex-snapshot
Rational engineering of isoform-specific hSULT1E1 fluorogenic substrates for functional analysis and inhibitor screening
inferred← citeshttps://doi.org/10.1016/j.cbi.2025.111682openalex-snapshot
In vitro inhibition effect of various pharmacologically relevant drugs on recombinant paraoxonase 1
inferred← citeshttps://doi.org/10.1016/j.dmd.2025.100158openalex-snapshot
Mechanistic insights into human carboxylesterase 2 (CES2) inhibition by the CES1 prodrug substrate remdesivir
inferred← citeshttps://doi.org/10.1016/j.fbio.2025.107056openalex-snapshot
6,7-Dimethoxy-3H-Quinazolin-4-One as a dual-function inhibitor of polyphenol oxidase and bacteria: biological evaluation, mode of action, and anti-browning studies
inferred← citeshttps://doi.org/10.1016/j.inoche.2024.112839openalex-snapshot
Novel thorned Ag4V2O7 nanorods: Intrinsic oxidase-like catalytic activity for antibacterial application
inferred← citeshttps://doi.org/10.1016/j.jpet.2025.103663openalex-snapshot
Impacts of anti-drug antibodies on pharmacokinetic and pharmacodynamic actions of cell-permeable middle molecule peptide drug
inferred← citeshttps://doi.org/10.1016/j.microc.2026.119894openalex-snapshot
Insights into the novel mechanisms in black ginseng flower, studies on screening, isolation and validation of AChE inhibitor for treating Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.slasd.2022.09.003openalex-snapshot
High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery
inferred← citeshttps://doi.org/10.1016/j.slasd.2025.100250openalex-snapshot
An enzyme activity-based workflow for the identification and characterization of covalent inhibitors
inferred← citeshttps://doi.org/10.1016/j.trac.2026.119089openalex-snapshot
From affinity to kinetics: SPR as the analytical backbone of AI-driven drug discovery
inferred← citeshttps://doi.org/10.1021/acs.jcim.5c00952openalex-snapshot
Kinetic Modeling of Covalent Inhibition: Effects of Rapidly Fluctuating Intermediate States
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00292openalex-snapshot
Use of the Novel Site-Directed Enzyme Enhancement Therapy (SEE-Tx) Drug Discovery Platform to Identify Pharmacological Chaperones for Glutaric Acidemia Type 1
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00131openalex-snapshot
Quantitation and Error Measurements in Dose–Response Curves
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02299openalex-snapshot
Innovative Medicinal Chemistry Strategies for Improving Target Binding Kinetics in Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02374openalex-snapshot
Resolving Enzyme–Substrate–Activator Ambiguity: A Minimalist Enzyme Kinetic Framework for PROTAC Design and Optimization
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c02860openalex-snapshot
K i Revisited: Principles, Pitfalls, and Best Practices for Measuring Enzyme Inhibitor Affinity
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.4c00054openalex-snapshot
Fitting of kinact and KI Values from Endpoint Pre-incubation IC50 Data
inferred← citeshttps://doi.org/10.1021/acsptsci.5c00412openalex-snapshot
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors
inferred← citeshttps://doi.org/10.1039/d5md00035aopenalex-snapshot
Navigating the complexities of drug development for metallo-β-lactamase inhibitors
inferred← citeshttps://doi.org/10.1080/10242422.2026.2671855openalex-snapshot
Kinetic characterization of Streptomyces griseus protease: A comparative study of linear and non-linear regression methods
inferred← citeshttps://doi.org/10.1080/10826068.2023.2249100openalex-snapshot
PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase
inferred← citeshttps://doi.org/10.1093/bioinformatics/btag709openalex-snapshot
Katalyst: knowledge-guided semantic alignment via contrastive learning for enzyme turnover prediction
inferred← citeshttps://doi.org/10.1111/1750-3841.17322openalex-snapshot
Inhibition of polyphenol oxidase for preventing browning in edible mushrooms: A review
inferred← citeshttps://doi.org/10.1111/bph.70064openalex-snapshot
Time‐evolved metrics for safety pharmacological assessments of small molecules and biologics
inferred← citeshttps://doi.org/10.1111/bph.70604openalex-snapshot
Expanding the landscape of covalent drug discovery: irreversible targeting of non‐cysteine residues
inferred← citeshttps://doi.org/10.1111/febs.16796openalex-snapshot
Unravelling the complexity of enzyme catalysis
inferred← citeshttps://doi.org/10.1139/bcb-2025-0264openalex-snapshot
A practical consideration for the substrate concentration when determining IC 50 values for enzyme inhibition
inferred← citeshttps://doi.org/10.1208/s12248-024-00966-yopenalex-snapshot
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker Assessment
inferred← citeshttps://doi.org/10.18097/pbmcr1536openalex-snapshot
Slow-binding inhibitors of enzymes: kinetic characteristics and pharmacological interest
inferred← citeshttps://doi.org/10.3389/frai.2026.1711471openalex-snapshot
KmPred: prediction of Michaelis constants (Km) using an integrative machine learning framework
inferred← citeshttps://doi.org/10.3390/biom16071049openalex-snapshot
AUKAT: Conditional VAE-Driven Augmentation and Neural Modeling of Enzyme Turnover Numbers
inferred← citeshttps://doi.org/10.3390/bios14020093openalex-snapshot
Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer’s Disease Drug Determination
inferred← citeshttps://doi.org/10.3390/catal15121139openalex-snapshot
Bridging Disciplines in Enzyme Kinetics: Understanding Steady-State, Transient-State and Performance Parameters
inferred← citeshttps://doi.org/10.3390/ijms252312767openalex-snapshot
Redefining Roles: A Paradigm Shift in Tryptophan–Kynurenine Metabolism for Innovative Clinical Applications
inferred← citeshttps://doi.org/10.3390/ph18111606openalex-snapshot
Structure-Based Insights into Stefin-Mediated Targeting of Fowlerpain-1: Towards Novel Therapeutics for Naegleria fowleri Infections
inferred← citeshttps://doi.org/10.3390/pharmaceutics15030966openalex-snapshot
Radiothermal Emission of Nanoparticles with a Complex Shape as a Tool for the Quality Control of Pharmaceuticals Containing Biologically Active Nanoparticles
inferred← citeshttps://doi.org/10.64898/2026.01.19.700244openalex-snapshot
PocketGNN: A Cross-Modal Framework Unifying Local 3D Pocket Geometry and Global Sequence Semantics for Enzyme Kinetic Prediction
inferred← citeshttps://doi.org/10.64898/2026.08.13.743369openalex-snapshot
On the determinants of residence times and dissociation mechanisms of complexes of interleukin-13 with its low and high affinity receptors
inferred← citeshttps://doi.org/10.9734/afsj/2024/v23i7725openalex-snapshot
An Analysis of Health Risk and Potential Elimination Strategies of Anti-nutritional Factors in Cereals and Legumes
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.